Program

 

Day 1 - Thursday, 19 September 2019

 
 08:45 Opening of the workshop 
 Session 1: Epidemiology of HIV and hepatitis in the CEE countries and access to care
 
 09:00Epidemiology of viral hepatitis infection and treatment in Europe
Speaker to be confirmed
 
 9:30

Epidemiology of HIV infection and treatment in Europe
Teymur Noori, ECDC, Stockholm, Sweden

 
 10:00Where we are in terms of providing access and where we should go
Speaker to be confirmed
 
    
 10:30 Coffee break and poster viewing 
    
 Session 2: Access to care
 
 11:00 

EECA: are we lagging behind?  
Sergey Golovin, ITPCru, St. Petersburg, Russia

 
 11:10 

Access to quality assured  (WHO prequalified) generic medicines in the region
Liudmyla Maistat, Medicines Patent Pool, Geneva, Switzerland

 
 11:20

Dedes, Nicos 2019
Access to key populations
Nikos Dedes, EATG, Greece

 
 11:30Roundtable discussion 
    
 Session 3: HIV and hepatitis coinfection
 
 11:45

Management of HIV/HCV in young women
Vadim Rassokhin, MD, 1st St. Petersburg State Medical University "Acad. I.P. Pavlov", St. Petersburg, Russia

 
 12:00 Abstract-driven presentations 
 12:20Discussion 
    
 12:30Group picture and lunch 
    
 13:30Industry-sponsored symposium 
    
 Session 4: PrEP
 
 14:30

PrEP and STI testing in CEE: What are the barriers, what works?
Milosz Parczewski, MD, PhD, Pomeranian Medical University, Sczecin, Poland

 
 15:20Panel discussion 
 15:30 Coffee break and poster viewing 
    
 16:00Industry-sponsored symposium 
    
 Session 5: Linkage to care and management of treatment failure in HIV
 
 17:00

Switching to second-line HIV therapy
Pavel Khaykin, MD, MainFachArzt, Frankfurt, Germany

 
 17:30

Raben, DortheIntegrated testing for HIV, hepatitis, and STIs
Dorthe Raben, MSc, CHIP, Copenhagen, Denmark

 
 18:00Discussion 
    
 18:15End of day 1
Welcome reception and poster viewing
 
 19:30 Group dinner
 
    
 

Day 2 - Friday, 20 September 2019

 
    
 Session 6: HIV and Tuberculosis coinfection
 
 9:00Management TB  and HIV infection
Daria Podlekareva, MD 
University of Copenhagen, Copenhagen, Denmark
 
 9:30

The challenging TB case: clinical, virological and pharmacological considerations
Jonathan Schapiro, MD, Sheba Medical Centre, Tel Aviv, Israel

 
 10:00 Abstract-driven presentations 
    
 10:30Coffee break and poster viewing 
    
 Session 7
 
 11:00 Abstract - driven presentations 
    
 12:00 Lunch 
    
 13:00 Industry-sponsored symposium 
    
 Session 8: Hot topics in HIV and Hepatitis
 
 14:00Schwarze-Zander, CarolynneVaccinations for HIV patients: which vaccinations when and how?
Carolynne Schwarze-Zander, PhD, University of Bonn, Bonn, Germany
 
 14:25

Treatment of Hepatitis B: What are the remaining challenges?
Olga Golubovska, MD, PhD, Bogomolets National Medical University, Kyiv, Ukraine

 
 14:50

Ligita JančorienėHIV/HCV coinfection: Influence on risk for cancer and cardiovascular events, and impact of successful HCV cure 
Ligita Jancoriene, MD, PhD, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania

 
 15:15 0Hepatitis E in HIV-infected patients
Speaker to be confirmed
 
    
 15:40 End of conference